Medcaw Investments (MCI) Competitors Add Compare Share Share Competitors Stock AnalysisChartCompetitorsBuy This Stock MCI vs. BGHL, EDGI, SEED, ADL, ATY, MNTC, BRH, ALGW, D467, and CMBShould you be buying Medcaw Investments stock or one of its competitors? The main competitors of Medcaw Investments include Boussard & Gavaudan EUR (BGHL), Edge Performance VCT Public (EDGI), Seed Innovations (SEED), Andalas Energy and Power (ADL), Athelney Trust (ATY), The Schiehallion Fund (MNTC), Braveheart Investment Group (BRH), Alpha Growth (ALGW), Thames Ventures VCT 2 DP67 (D467), and Cambria Africa (CMB). These companies are all part of the "asset management" industry. Medcaw Investments vs. Boussard & Gavaudan EUR Edge Performance VCT Public Seed Innovations Andalas Energy and Power Athelney Trust The Schiehallion Fund Braveheart Investment Group Alpha Growth Thames Ventures VCT 2 DP67 Cambria Africa Medcaw Investments (LON:MCI) and Boussard & Gavaudan EUR (LON:BGHL) are both small-cap financial services companies, but which is the better investment? We will contrast the two companies based on the strength of their profitability, media sentiment, institutional ownership, earnings, risk, analyst recommendations, valuation, dividends and community ranking. Which has higher valuation and earnings, MCI or BGHL? Medcaw Investments has higher earnings, but lower revenue than Boussard & Gavaudan EUR. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMedcaw InvestmentsN/AN/AN/A-£0.04N/ABoussard & Gavaudan EUR£3.79M0.00-£2.68M-£0.21N/A Is MCI or BGHL more profitable? Medcaw Investments has a net margin of 0.00% compared to Boussard & Gavaudan EUR's net margin of -70.69%. Boussard & Gavaudan EUR's return on equity of -0.78% beat Medcaw Investments' return on equity.Company Net Margins Return on Equity Return on Assets Medcaw InvestmentsN/A -51.13% -10.82% Boussard & Gavaudan EUR -70.69%-0.78%-0.36% Does the MarketBeat Community believe in MCI or BGHL? Boussard & Gavaudan EUR received 55 more outperform votes than Medcaw Investments when rated by MarketBeat users. CompanyUnderperformOutperformMedcaw InvestmentsN/AN/ABoussard & Gavaudan EUROutperform Votes5571.43% Underperform Votes2228.57% Do institutionals and insiders have more ownership in MCI or BGHL? 11.3% of Boussard & Gavaudan EUR shares are owned by institutional investors. 27.5% of Medcaw Investments shares are owned by insiders. Comparatively, 16.2% of Boussard & Gavaudan EUR shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Does the media prefer MCI or BGHL? In the previous week, Medcaw Investments' average media sentiment score of 0.00 equaled Boussard & Gavaudan EUR'saverage media sentiment score. Company Overall Sentiment Medcaw Investments Neutral Boussard & Gavaudan EUR Neutral SummaryBoussard & Gavaudan EUR beats Medcaw Investments on 5 of the 9 factors compared between the two stocks. Remove Ads Get Medcaw Investments News Delivered to You Automatically Sign up to receive the latest news and ratings for MCI and its competitors with MarketBeat's FREE daily newsletter. Email Address MCI vs. The Competition Export to ExcelMetricMedcaw InvestmentsAsset Management IndustryFinancial SectorLON ExchangeMarket Cap£891,000.00£1.04B£3.58B£2.35BDividend YieldN/A4.45%4.20%4.95%P/E Ratio-100.6323.6013.82124.62Price / SalesN/A2,207.501,647.36262,424.19Price / CashN/A60.9449.2727.93Price / BookN/A1.043.284.29Net IncomeN/A£260.34M£1.25B£5.79B Medcaw Investments Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MCIMedcaw InvestmentsN/AN/AN/AN/A£891,000.00N/A-100.633High Trading VolumeBGHLBoussard & Gavaudan EURN/AN/AN/AN/A£3.41M£3.79M-131.90N/AEDGIEdge Performance VCT PublicN/AN/AN/AN/A£3.39M£9.72M0.37N/AGap DownSEEDSeed InnovationsN/AGBX 1.60-0.1%N/A-18.0%£3.14M£-487,033.83-2.1852Gap DownHigh Trading VolumeADLAndalas Energy and PowerN/AN/AN/AN/A£3.12M£16,000.00-0.406Gap UpATYAthelney TrustN/AGBX 143+2.1%N/A-13.2%£3.09M£-1,880,000.00-1,588.891Gap UpMNTCThe Schiehallion FundN/AN/AN/AN/A£3.08M£-256,110,000.004.89N/APositive NewsGap DownBRHBraveheart Investment GroupN/AGBX 4.60-8.0%N/A-31.8%£2.93M£1.24M-0.455News CoverageGap DownALGWAlpha GrowthN/AGBX 0.60+26.3%N/A-60.6%£2.89M£4.16M-1.854Gap UpHigh Trading VolumeD467Thames Ventures VCT 2 DP67N/AN/AN/AN/A£2.69MN/A-1,200.00N/AGap DownCMBCambria AfricaN/AN/AN/AN/A£2.45M£1.41M-3.759 Remove Ads Related Companies and Tools Related Companies Boussard & Gavaudan EUR Alternatives Edge Performance VCT Public Alternatives Seed Innovations Alternatives Andalas Energy and Power Alternatives Athelney Trust Alternatives The Schiehallion Fund Alternatives Braveheart Investment Group Alternatives Alpha Growth Alternatives Thames Ventures VCT 2 DP67 Alternatives Cambria Africa Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:MCI) was last updated on 4/11/2025 by MarketBeat.com Staff From Our PartnersTrump’s Secret WeaponHave you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's...American Alternative | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredAll Signs Point To Collapse - 401(k)s/IRAs /Are DoomedRetiring? Not so Fast..Hold Onto Your Bootstraps For A Long Road AheadAmerican Hartford Gold | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Medcaw Investments Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Medcaw Investments With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
